ArticleOncotarget2023
CDK9 INHIBITORS: a promising combination partner in the treatment of hematological malignancies.
Daniel Morillo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleOncotarget2023
Daniel Morillo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.